Research & Development: Page 46
-
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool DR. JOHN ORLOFF Baxter Appoints VP of BioScience R&D Baxter International has appointed John Orloff, M.D., as VP and global head of research and development for Baxter BioScience. Dr. Orloff joins Baxter from Merck Serono Pharmaceuticals, where he served as global head of clinical...
By Ann Grey • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
On the Calendar
Now in its ninth year, the Site Solutions Summit is dedicated exclusively to helping clinical research sites reach optimal performance. With a foundation built on strengthening the site through industry partnership, the Summit has grown to be a community dedicated to driving clinical research suc...
By PharmaVoice Team • Aug. 28, 2014 -
Explore the Trendline➔
Stock via Getty Images
TrendlineOncology
As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Social Buzz
A collection of social media news, events, and strategies. Trending now: Mobile technology improves patient outcomes. A randomized control trial conducted through the Montefiore Medical Center earlier this year found a significant improvement in a number of key patient engagement metrics when car...
By Taren Grom • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry Prescription Drug Misuse Trending now: A three-year analysis of more than 1.4 million drug test results shows majority of Americans continue to put health at risk through dangerous drug combinations and skipping doses. Five s...
By Denise Myshko • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
BIO Launches BizLink Trending Now: New resource connects biotech and pharma companies with service providers. The Biotechnology Industry Organization (BIO) has launched BIO BizLink. Powered by OnDeckBiotech, BIO BizLink is positioned to become the industry’s leading resource for connecting biotec...
By Denise Myshko • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies Virtual Library of Deprioritized Compounts Part of Unique Partnership U.K. researchers have access to compounds through a new partnership between the Medical Research Council (MRC) and seven global drug companies. AstraZeneca, GlaxoSmithKli...
By Ann Grey • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A Single Pill for Multiple Viruses The treatment of viral infections is an unmet medical need. While many viruses such as rhinoviruses, which cause the cold, are not considered serious, others, such as ebola, are. There are more than 200 viruses that cause mild-to-severe diseases that have limite...
By Lillian Chiang • Aug. 28, 2014 -
PharmaVoice Team/PharmaVoice
Future Breakthroughs
The PharmaVOICE 100 discuss what’s on the research and commercialization horizons The PharmaVOICE 100 honorees had much to say about where they thought future breakthroughs will be. On the development side, personalized medicine and advances in cancer immunology will create new breakthrough treat...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
10 Years of Honorees
PharmaVOICE Honoree Year(s) Adrian Adams 2012 Colleen Adams 2009 Julian Adams, Ph.D. 2008, 2011 Thomas Adams 2005 Jeffrey Adelglass, M.D. 2014 Lisa Adler 2014 Ann Aerts, M.D. 2014 Michael Agard 2010 Gadi Aharoni, Ph.D. 2006 Christopher Ahlberg, Ph.D. 2005 Mark J. Ahn, Ph.D. 2005 Murray L. Aitken ...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Red Jacket Awards
In celebration of 10 years of the PharmaVOICE 100, we are proud to launch the Red Jacket Award. This honor recognizes individuals who have been nominated multiple times by their colleagues and peers as inspirational leaders. Throughout their careers, they have demonstrated a commitment to further...
By PharmaVoice Team • July 28, 2014 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
John Glasspool Changing the Access Conversation Driven to innovate by People Market access is dead and the new driver of change and progress in healthcare is patient access. That’s the view of John Glasspool, who heads Baxter’s global market development program. With a dedicated focus on patient ...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
The Mentors
John White Mentor, Expert, Leader Driven to innovate by Possibilities Last year, John White ran 60-kilometers (37 miles) to celebrate his 60th birthday. Not only did he complete the race, but he used the event to create a fundraiser for the American Cancer Society (ACS). Called the 60 for 60 Race...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
The Clinical Specialists
Michael Brooks Energy for the Long Run Driven to Innovate by Instinct Michael Brooks is a visionary leader who helped create a groundbreaking way for PPD to serve the needs of its biopharmaceutical clients. Under Mr. Brooks’ direction, the company employed several state-of-the-art technologies to...
By PharmaVoice Team • July 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 - Who's on the List by Section
These extraordinary leaders, representing a wide range of industry sectors and functional areas of expertise, are having a positive impact on their colleagues, their companies, and the greater healthcare community. See who you know! Who’s on the List — 2014 Indexed by Section The Academics Dr. Mo...
By Taren Grom • July 28, 2014 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts TMF Survey Reveals Lagging Technology Adoption and Use of Manual Processes Trending now: Although advanced eTMF technologies improve inspection readiness and compliance while reducing costs, a majority still use paper or electronic files...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Veeva Systems Introduces Commercial Cloud for Life Sciences Trending Now: New industry cloud brings together master data, compliant content, and customer interactions across all channels to transform commercial operations. Veeva Systems has unveiled Commercial Cloud, a next-generation solution to...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
What's New
Global Outcomes Group Launches to Support Outcomes Research Trending Now: New full-service medical communications agency focuses on supporting growing health economics and outcomes research in biopharma industry. The Global Outcomes Group has been formed to support the content and communication n...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
2014 PharmaVOICE 100 - Who's on the List by Company
Who’s on the List — 2014 Indexed by Company Affiliation AbelsonTaylor – Dr. Jeffrey Berg Advanced Clinical LLC – Susan Seroskie Advanced Clinical LLC – Julie Ross Baxter Healthcare Corp. – John Glasspool BBK Worldwide – Aaron Fleishman BioClinica Inc. – Dr. Boaz Mendzelevski Biogen Idec – Dr. Kat...
By Robin Robinson • July 28, 2014 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Kowa and Football Player Help those with High Cholesterol Kowa Pharmaceuticals America has announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife Brenda, to launch First and Goal, a national education initiative to help people prioritize h...
By Denise Myshko • July 28, 2014 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The 2014 PharmaVOICE 100 The PharmaVOICE 100 Turns 10! It’s hard to believe that 10 years after the vision for this issue was captured on the back of a napkin during a long flight delay, we have now profiled 1,000 of the industry’s most inspirational and motivational individuals making this issue...
By Taren Grom • July 28, 2014 -
PharmaVoice Team/PharmaVoice
New Considerations for the Design and Execution of Immuno-Oncology Drug Trials
There is much excitement in the field of immuno-oncology drugs with the approval of sipuleucel-T (Provenge), ipilimumab (Yervoy), and the very promising data on other checkpoint modulators, new oncolytic viruses, and therapeutic vaccines on the horizon. There are some important adjustments in tre...
By Jeffrey Weisberg • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Top 10 Clinical Trial Cost-Cutting Innovations
The challenges associated with conducting and managing today’s clinical trials have never been greater. According to a recent survey, clinical trials today cost 60% more than they did five years ago. Primary cost drivers include trial site startup (i.e., training, systems setup and access, regula...
By Sandra R. Lottes • May 29, 2014 -
PharmaVoice Team/PharmaVoice
How Information Technology is Enhancing Clinical Trials Recruitment and Participation
New platforms and technology today are able to help keep the right physicians apprised of the right open trials — communicating information efficiently across multiple locations in a large geographical area. Pharmaceutical companies have long struggled to achieve clinical trial recruitment goals....
By Jeff Meehan • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Mapping Your Workforce Genome
What if you could plan out your workforce needs with the precision that we see in well-crafted R&D protocols and personalized medicine? And what if you could look at your human capital engagements and the available “talent supply chain" in the way science has started to look at sustaining hea...
By Mark A. Lanfear • May 29, 2014 -
PharmaVoice Team/PharmaVoice
Data-Driven Approaches Accelerate Trial Recruitment and Quantify Risk
At one time, biopharmaceutical companies could develop their clinical trial recruitment strategies using nothing more than historical experience, anecdotal knowledge, and gut instinct. They could trust investigators to supply the necessary patients, and as a last resort, bolt on some media covera...
By Ramita Tandon • May 29, 2014
Previous
